| Click Here to receive daily reports of the TOP PICKS OR your personal stock choices | STOCKCHASEWhat the experts are saying! |
| There are 8 registered members and 56 guests viewing the site. | Follow us on Twitter | Rss Top Picks Feed | Rss Daily Feed |
|
| HOLD | 34.900 | Norman Levine | GlaxcoSmithKline (GSK-N) is taking the company over. Speculation is that someone else will come in with a better offer. Can't see much risk in holding on to your shares. | 2005-09-20 | |
| BUY | 21.500 | Jean-Francois Tardif | Have a large vaccine contract in the US. Should have a large increase in earnings and the stock should have a lot of upside. | 2005-05-09 | |
| DON'T BUY | 20.050 | Jean-Francois Tardif | Biotech stocks are very risky. This one has done very well on the flu vaccine problem in the US. A low margin business. Very expensive. | 2004-12-03 | |
| BUY | 14.640 | Robert Floyd | The pharmaceutical sector has been torn apart. This company that has done a very good job in managing and developing some products. | 2004-08-23 | |
| BUY on WEAKNESS | 25.470 | Robert Floyd | Likes the story. Has had a pretty good run, but has more room to go. Very strong news out of the company. Some trial results still to come out in the next little while. | 2003-09-22 | |
| BUY on WEAKNESS | 17.540 | Peter Hodson | Developing a flu vaccine. Well cashed up. Would buy it, but at a lower level. | 2003-07-29 | |
| BUY | 8.160 | Robert Floyd | Good product. In final phases of testing. | 2003-03-03 | |
| WEAK BUY | 10.060 | Peter Hodson | Very volatile. Well managed and has a lot of cash. | 2003-02-04 | |
| BUY | 11.450 | Robert Floyd | Still has substantial upside. Into some interesting products. | 2003-01-15 | |
| PAST TOP PICK | 9.610 | Robert Floyd | (Was a top pick on Dec 21 up 50%) Can still go higher. | 2002-04-05 | |
| TOP PICK | 6.640 | Robert Floyd | Well capitalized. Strong management. | 2001-12-21 | |
| TOP PICK | 5.150 | Robert Floyd | 2001-07-09 | ||
| TOP PICK | 6.400 | Robert Floyd | Strong cash position. Good mngmnt. Good outlook. | 2001-06-14 | |
| TOP PICK | 5.950 | Robert Floyd | Well capitalized. Good product line. | 2001-05-14 | |
| TOP PICK | 4.810 | Robert Floyd | New acquisition is a good fit. Strong cash positions. | 2001-03-28 | |
| BUY | 6.700 | Pier Donnini | Likes. Has dropped, but some exciting things coming up on it. | 2001-03-06 | |
| STRONG BUY | 8.000 | Malvin Spooner | Great company and at a good price | 2001-01-31 | |
| BUY | 9.000 | Robert Floyd | Well capitalized. Applications in stage 3 | 2000-11-01 | |
| TOP PICK | 10.000 | Malvin Spooner | Their software is needed by pharmaceuticals working in genomics | 2000-10-24 |